Turner Medical Sciences Long/Short Instl
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
N/A
1 yr return
-9.2%
3 Yr Avg Return
4.3%
5 Yr Avg Return
5.9%
Net Assets
$31.8 M
Holdings in Top 10
24.9%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 3.53%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 210.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$100,000
IRA
$100,000
Fund Classification
Fund Type
Open End Mutual Fund
Name
As ofPrice
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
TMSEX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return 4.3%
- 5 Yr Annualized Total Return 5.9%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -2.38%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameTurner Medical Sciences Long/Short Fund
-
Fund Family NameTurner Funds
-
Inception DateFeb 07, 2011
-
Shares OutstandingN/A
-
Share ClassInst
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerJohn P. Fraunces
Fund Description
TMSEX - Performance
Return Ranking - Trailing
Period | TMSEX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -14.5% | 32.5% | N/A |
1 Yr | -9.2% | -26.8% | 13.4% | N/A |
3 Yr | 4.3%* | -25.8% | 13.6% | N/A |
5 Yr | 5.9%* | -24.7% | 12.0% | N/A |
10 Yr | N/A* | -12.4% | 10.8% | N/A |
* Annualized
Return Ranking - Calendar
Period | TMSEX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -24.8% | 12.7% | N/A |
2022 | N/A | -46.3% | 26.8% | N/A |
2021 | N/A | -20.0% | 25.3% | N/A |
2020 | N/A | -22.2% | 14.0% | N/A |
2019 | N/A | -24.3% | 60.7% | N/A |
Total Return Ranking - Trailing
Period | TMSEX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -14.5% | 32.5% | N/A |
1 Yr | -9.2% | -26.6% | 13.4% | N/A |
3 Yr | 4.3%* | -9.2% | 13.6% | N/A |
5 Yr | 5.9%* | -9.4% | 15.9% | N/A |
10 Yr | N/A* | -7.5% | 13.2% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | TMSEX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -24.8% | 12.7% | N/A |
2022 | N/A | -12.7% | 26.8% | N/A |
2021 | N/A | -15.5% | 25.3% | N/A |
2020 | N/A | -17.3% | 22.6% | N/A |
2019 | N/A | -15.0% | 64.3% | N/A |
TMSEX - Holdings
Concentration Analysis
TMSEX | Category Low | Category High | TMSEX % Rank | |
---|---|---|---|---|
Net Assets | 31.8 M | 2.32 M | 8.1 B | N/A |
Number of Holdings | 38 | 3 | 2278 | N/A |
Net Assets in Top 10 | 13 M | -162 M | 2.09 B | N/A |
Weighting of Top 10 | 24.86% | 0.0% | 98.8% | N/A |
Top 10 Holdings
- Pfizer Inc 2.62%
- GlaxoSmithKline PLC ADR 2.62%
- Allergan PLC 2.62%
- Abbott Laboratories 2.55%
- Merck & Co Inc 2.49%
- UnitedHealth Group Inc 2.46%
- Edwards Lifesciences Corp 2.46%
- bluebird bio Inc 2.42%
- C.R. Bard Inc 2.38%
- Ionis Pharmaceuticals Inc 2.23%
Asset Allocation
Weighting | Return Low | Return High | TMSEX % Rank | |
---|---|---|---|---|
Stocks | 54.64% | -0.11% | 107.30% | N/A |
Cash | 45.14% | -17.34% | 100.06% | N/A |
Other | 0.21% | -4.18% | 46.57% | N/A |
Preferred Stocks | 0.00% | -0.64% | 2.67% | N/A |
Convertible Bonds | 0.00% | -0.01% | 2.82% | N/A |
Bonds | 0.00% | -9.01% | 92.61% | N/A |
Stock Sector Breakdown
Weighting | Return Low | Return High | TMSEX % Rank | |
---|---|---|---|---|
Healthcare | 54.64% | -2.86% | 48.92% | N/A |
Utilities | 0.00% | -4.19% | 11.21% | N/A |
Technology | 0.00% | -4.90% | 37.98% | N/A |
Real Estate | 0.00% | -9.01% | 40.55% | N/A |
Industrials | 0.00% | -9.10% | 21.99% | N/A |
Financial Services | 0.00% | 0.00% | 33.33% | N/A |
Energy | 0.00% | 0.00% | 18.75% | N/A |
Communication Services | 0.00% | -4.54% | 10.19% | N/A |
Consumer Defense | 0.00% | -7.58% | 18.29% | N/A |
Consumer Cyclical | 0.00% | -6.55% | 27.34% | N/A |
Basic Materials | 0.00% | -2.16% | 16.56% | N/A |
Stock Geographic Breakdown
Weighting | Return Low | Return High | TMSEX % Rank | |
---|---|---|---|---|
US | 48.82% | -0.11% | 105.83% | N/A |
Non US | 5.82% | -0.84% | 93.74% | N/A |
TMSEX - Expenses
Operational Fees
TMSEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 3.53% | 0.42% | 4.90% | N/A |
Management Fee | 1.50% | 0.25% | 2.25% | N/A |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | 0.15% | 0.01% | 0.55% | N/A |
Sales Fees
TMSEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 2.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
TMSEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
TMSEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 210.00% | 0.00% | 5067.00% | N/A |
TMSEX - Distributions
Dividend Yield Analysis
TMSEX | Category Low | Category High | TMSEX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 0.12% | N/A |
Dividend Distribution Analysis
TMSEX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Annually | Annually |
Net Income Ratio Analysis
TMSEX | Category Low | Category High | TMSEX % Rank | |
---|---|---|---|---|
Net Income Ratio | -2.38% | -2.95% | 1.42% | N/A |
Capital Gain Distribution Analysis
TMSEX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
TMSEX - Fund Manager Analysis
Managers
John P. Fraunces
Start Date
Tenure
Tenure Rank
Feb 27, 2015
1.84
1.8%
John P. Fraunces, Jr. Portfolio Manager/Global Equity Analyst Turner Investments John Fraunces is a Portfolio Manager/Global Equity Analyst on Turner’s health care team and Co-Portfolio Manager of the Global Medical Sciences Long/Short strategy. Mr. Fraunces joined Turner in 2015 covering stocks in the health care sector and has 20 years of investment experience. Prior to joining Turner Investments, Mr. Fraunces was a managing member and portfolio manager of Synaptic Capital Group, LLC. He previously held portfolio management, analyst, research, and consulting positions at Solaris Asset management LLC, Gardner Lewis Asset Management, Vector Securities International, PaineWebber Incorporated, IMS America, Ltd, and Magainin Pharmaceuticals, Inc. Mr. Fraunces earned his MBA at Lehigh University and earned a bachelor’s degree in chemistry at University of Scranton.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.18 | 41.03 | 6.74 | 5.53 |